105 results
424B2
PLSE
Pulse Biosciences Inc
4 Jun 24
Prospectus for primary offering
4:05pm
Pulse Biosciences, Inc. is a novel bioelectric medicine company committed to health innovation using its patented Nano-pulse Stimulation ("NPS
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
4 Jun 24
Pulse Biosciences, Inc. Announces Commencement of Rights Offering
4:04pm
such state or jurisdiction.
About Pulse Biosciences®
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation
SD
EX-1.01
PLSE
Pulse Biosciences Inc
31 May 24
Conflict minerals disclosure
4:18pm
company committed to health innovation using its patented Nano-pulse Stimulation ("NPS") technology, a revolutionary energy modality that delivers
POS AM
PLSE
Pulse Biosciences Inc
28 May 24
Prospectus update (post-effective amendment)
5:19pm
Biosciences, Inc. is a novel bioelectric medicine company committed to health innovation using its patented Nano-pulse Stimulation ("NPS") technology
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
20 May 24
Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000
4:10pm
Biosciences®
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality
8-K
EX-99.1
d0b3laui7vd31
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
8-K
EX-99.1
zxs65b6pl7zwe wu0qk
9 May 24
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
9:09am
8-K
EX-99.1
f2ltjjn
7 May 24
Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results
4:14pm
8-K
EX-99.1
mwlabhc
2 May 24
Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000
9:09am
8-K
EX-99.2
b9tx4kla mf
28 Mar 24
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
4:18pm
8-K
EX-99.1
3iwcs95r8bo
28 Mar 24
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
4:18pm
8-K
EX-99.1
e7lsruwcxpgt3f9n50s
11 Mar 24
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
9:10am